Paper18802412
Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.
Weinbaum CM and 8 others. MMWR Recomm Rep, 2008. Cited by 516 papers, by iCite.
Cite this record
ConductScience Library. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Papers, record 18802412. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18802412
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B Surface Antigens | Major topic |
| Hepatitis B, Chronic | Major topic |
| Mass Screening | Major topic |
| Adolescent | |
| Adult | |
| Centers for Disease Control and Prevention, U.S. | |
| Child | |
| Contact Tracing | |
| DNA, Viral | |
| Female | |
| Hepatitis B Vaccines | |
| Hepatitis B virus | |
| Humans | |
| Male | |
| Population Surveillance | |
| Prevalence | |
| Public Health | |
| Risk Factors | |
| United States |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03471624 | Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF) | Background |
Source ClinicalTrials.gov
Cited by327
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 516 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42620045 | Divergent hepatitis B neutralizing antibody trajectories after spontaneous control in people with and without HIV. | Res Sq | 2026 | https://conductscience.org/library/papers/42620045 | PubMed |
| 42240959 | Hepatitis B Screening, Antiviral Prophylaxis, and Reactivation Risk in Rituximab-Treated Patients: A 17-Year Population-Based Cohort Study Highlighting Current Practices and Gaps. | Dig Dis Sci | 2026 | https://conductscience.org/library/papers/42240959 | PubMed |
| 42210247 | Serological epidemiology of hepatitis B virus and vaccine-induced immune dynamics in 58,169 children in Wuhan, China (2019-2025): a cross-sectional analysis of waning immunity and adolescent susceptibility. | Virol J | 2026 | https://conductscience.org/library/papers/42210247 | PubMed |
| 41351332 | Chronic Hepatitis B Virus Infection Acquired Under Cytostatic Treatment in Childhood - Clinical, Virological and Immunological Long-Term Follow-Up. | J Viral Hepat | 2026 | https://conductscience.org/library/papers/41351332 | PubMed |
| 41341015 | Knowledge, Attitudes, and Practices Regarding Hepatitis B and Liver Cancer Among Liver Cancer Patients and Their Families in China. | Cancer Manag Res | 2025 | https://conductscience.org/library/papers/41341015 | PubMed |
| 41335575 | Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti-HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trial. | Hepatol Commun | 2025 | https://conductscience.org/library/papers/41335575 | PubMed |
| 41003568 | Prevalence and Screening Rates of Hepatitis B and Hepatitis C Infections in Adult Patients with Solitary Organ Tumors. | Trop Med Infect Dis | 2025 | https://conductscience.org/library/papers/41003568 | PubMed |
| 40906889 | Identifying determinants of viral hepatitis and liver cancer care in Michigan Asian American communities through multilevel engagement. | Hepatol Commun | 2025 | https://conductscience.org/library/papers/40906889 | PubMed |
| 40736453 | Racial Disparities in Comorbidity Patterns of Early-Onset Liver Cancer: A Machine Learning Analysis. | Cancer Control | 2025 | https://conductscience.org/library/papers/40736453 | PubMed |
| 40260164 | Prevention practices of hepatitis B virus and its associated factors among barbers in East Gojjam Zone, Northwest Ethiopia. | Front Public Health | 2025 | https://conductscience.org/library/papers/40260164 | PubMed |
| 40048081 | Chronic Viral Hepatitis Screening Inequities Across Florida Federally Qualified Health Centers. | J Racial Ethn Health Disparities | 2026 | https://conductscience.org/library/papers/40048081 | PubMed |
| 39129946 | A Review of the Systemic Manifestations of Hepatitis B Virus Infection, Hepatitis D Virus, Hepatocellular Carcinoma, and Emerging Therapies. | Gastro Hep Adv | 2024 | https://conductscience.org/library/papers/39129946 | PubMed |
| 39129942 | The Epidemiology, Transmission, Genotypes, Replication, Serologic and Nucleic Acid Testing, Immunotolerance, and Reactivation of Hepatitis B Virus. | Gastro Hep Adv | 2024 | https://conductscience.org/library/papers/39129942 | PubMed |
| 39078109 | Self-reported hepatitis B testing among noninstitutionalized adults in the United States before the implementation of universal screening, 2013-2017: A nationwide population-based study. | J Viral Hepat | 2024 | https://conductscience.org/library/papers/39078109 | PubMed |
| 39046551 | Impact of universal hepatitis B virus (HBV) screening using chemotherapy orders on the HBV reactivation in cancer patients. | Support Care Cancer | 2024 | https://conductscience.org/library/papers/39046551 | PubMed |
| 39037155 | Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States. | J Viral Hepat | 2024 | https://conductscience.org/library/papers/39037155 | PubMed |
| 38839381 | Development of a risk prediction score for screening for HBV, HCV and HIV among migrants in France: results from a multicentre observational study (STRADA study). | BMJ Open | 2024 | https://conductscience.org/library/papers/38839381 | PubMed |
| 38353882 | Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy. | Drug Saf | 2024 | https://conductscience.org/library/papers/38353882 | PubMed |
| 38200947 | Disparities in Healthcare and HBV Vaccination by Smoking Status: Findings from the National Health and Nutrition Examination Survey (NHANES) 2017-2018. | Healthcare (Basel) | 2023 | https://conductscience.org/library/papers/38200947 | PubMed |
| 37554925 | Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus. | JHEP Rep | 2023 | https://conductscience.org/library/papers/37554925 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18802412
GET https://conductscience.org/api/papers/v1/18802412/cited_by?page=2